跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BUDENOFALK budesonide foam 2 mg cans - TGA Drug Approval Details
Approvals
/
TGA
/
BUDENOFALK budesonide foam 2 mg cans
Approved
STANDARD
BUDENOFALK budesonide foam 2 mg cans
Dr Falk Pharma Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
a1b8059117ff8642
Company
Dr Falk Pharma Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
a1b8059117ff8642
Product Name
BUDENOFALK budesonide foam 2 mg cans
Artg Id
179575
Artg Name
BUDENOFALK budesonide foam 2 mg cans
Sponsor
Dr Falk Pharma Australia Pty Ltd
Company Detail Path
/organization/dr-falk-pharma-australia-pty-ltd
Artg Date
2012-06-12
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/fb25a85061696745be228080a922d134.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/5b7beeddeb51f871fbc7b9dac11b769a.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
a1b8059117ff8642
Type
Standard
Back to TGA Approvals